ArticleCancer science2018

Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer.

Dong Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.